Clinical Trials Browser

Interventional × Gynecologic Tumors × pazopanib × Clear all

NCT00800345 2017-03-28

Phase I Trial of Oral Metronomic Topotecan and Oral Pazopanib to Treat Recurrent/Persistent Gynecologic Tumors

Phase 1 Completed

33 enrolled 7 charts

Gynecologic Tumors